Form 4: Fortive Director Sharmistha Dubey Boosts Equity Holdings Through Annual Grant and Deferred Compensation
Insider Transaction Report
Fortive Corp Director Sharmistha Dubey has increased her beneficial ownership of company common stock and acquired stock options through an annual equity grant and a deferral of cash compensation.
Summary
- On June 2, 2025, Sharmistha Dubey, a Director of Fortive Corp (FTV), acquired 3,100 shares of common stock in the form of Annual Grant Restricted Stock Units (RSUs) at a price of $0.
- These Annual Grant RSUs vest on the earlier of the first anniversary of the grant date or the date of and immediately prior to the Issuer's 2026 annual meeting of stockholders.
- The underlying shares for the Annual Grant RSUs will not be issued until the earlier of the Reporting Person's death or the first day of the seventh month following her retirement from the Board of Directors.
- Additionally, on June 2, 2025, Ms. Dubey acquired 2,790 shares of common stock as Deferral RSUs, based on a 20-day average price of $70.87, resulting from a deferral election of $197,500 in annual retainer that would otherwise have been paid in cash.
- The Deferral RSUs have similar vesting and issuance conditions to the Annual Grant RSUs.
- Ms. Dubey also acquired 3,130 Director Stock Options (right to buy) with an exercise price of $70.26, exercisable from June 2, 2025, and expiring on June 2, 2035.
- Following these transactions, Ms. Dubey's direct beneficial ownership of common stock increased to 22,873 shares, and she beneficially owns 3,130 derivative securities (stock options).
Sentiment
Score: 7
Explanation: The filing indicates a director's increased equity ownership through standard compensation practices, aligning their interests with shareholders, which is generally viewed positively as it signals commitment and confidence in the company's future.
Positives
- The transactions demonstrate a director's increased equity alignment with the company's performance and shareholder interests.
- The deferral of cash compensation into equity (Deferral RSUs) indicates confidence in the company's long-term value.
Future Outlook
The acquired restricted stock units are subject to future vesting conditions, primarily tied to the first anniversary of the grant date or the company's 2026 annual meeting, with the underlying shares to be issued upon the Reporting Person's death or retirement from the board. The stock options are exercisable immediately and have a ten-year term.
Industry Context
It is a common practice in the industry for publicly traded companies to compensate their directors with equity, such as restricted stock units and stock options, to align their interests with those of the shareholders and to incentivize long-term performance and retention. The deferral of cash compensation into equity is also a standard option offered to directors.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) and stock options as part of director compensation is a standard practice across many industries, including industrial technology companies like Fortive.
- The vesting schedule tied to an annual grant and the deferral mechanism for cash compensation are typical structures seen in corporate governance for non-employee directors.
- The specific values and number of shares granted are commensurate with compensation packages for directors at companies of similar market capitalization and industry standing, though no specific comparable companies or projects are detailed in this filing.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | The filing details the grant of restricted stock units and stock options as part of the annual equity compensation for a non-employee director, including a mechanism for deferring cash retainer into equity. | 06/02/2025 | Reinforces alignment of director's financial interests with long-term shareholder value through equity ownership and deferred compensation. |
Stakeholder Impact
- Shareholders: Benefit from increased alignment of a director's interests with the company's long-term performance through equity ownership.
- Employees: No direct impact mentioned, but general positive signal from director commitment.
Next Steps
- Vesting of the Annual Grant RSUs and Deferral RSUs on the earlier of June 2, 2026, or the date immediately prior to the Issuer's 2026 annual meeting of stockholders.
- Issuance of shares underlying the RSUs upon the earlier of the Reporting Person's death or the first day of the seventh month following her retirement from the Board of Directors.
- Potential exercise of Director Stock Options at any time between June 2, 2025, and June 2, 2035.
Key Dates
| Date | Description |
|---|---|
| 06/02/2025 | Date of grant for Annual Grant RSUs, Deferral RSUs, and Director Stock Options. |
| 06/04/2025 | Date the Form 4 filing was signed. |
| 2026 | Approximate year of the Issuer's annual meeting of stockholders, which is a vesting condition for the RSUs. |
| 06/02/2035 | Expiration date of the Director Stock Options. |
Recommendation
holdKeywords
Fortive Corp, FTV, Form 4, insider transaction, beneficial ownership, restricted stock units, RSUs, stock options, director compensation, equity grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.